ArticleBritish journal of cancer2007

A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer.

A Mercalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.